SWOG clinical trial number
SWOG-9207
Phase II Trial of Edatrexate Plus Carboplatin in Metastatic Non-Small Cell Lung Cancer
Closed
Phase
Accrual
62%
Published
Abbreviated Title
Phase II Trial of Edatrexate Plus Carboplatin in Metastatic Non-Small Cell Lung Cancer
Activated
01/01/1993
Closed
06/01/1995
Research committees
Lung Cancer
Publication Information Expand/Collapse
1997
Phase II trial of edatrexate plus carboplatin in metastatic non-small cell lung cancer: A Southwest Oncology Group study.
1996
Edatrexate and carboplatin in stage IV non-small cell lung cancer: Phase II trial of the Southwest Oncology Group (SWOG).
Other Clinical Trials
SWOG Clinical Trial Number
S2302
PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
77%
Open
Phase
SWOG Clinical Trial Number
A082002
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007
RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open